P

Puma Biotechnology
D

PBYI

5.89000
USD
0.02
(0.26%)
مغلق
حجم التداول
6,370
الربح لكل سهم
1
العائد الربحي
-
P/E
10
حجم السوق
296,803,620
أصول ذات صلة المقالات

العنوان: Puma Biotechnology

القطاع: Healthcare
الصناعة: Biotechnology
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.